共查询到20条相似文献,搜索用时 62 毫秒
1.
2.
3.
以茄呢醇为起始原料和茄呢基哌嗪为关键中间体合成了 4个N 酰基 N′ 茄呢基哌嗪 ( 4a~ 4d) ,以及 2个含葡萄糖单元的N ( 2 全乙酰葡萄糖基苯甲酰基 ) N′ 茄呢基哌嗪 ( 5 )和N ( 2 葡萄糖基苯甲酰基 ) N′ 茄呢基哌嗪 ( 6) ,共 6个新茄呢基哌嗪衍生物 .其结构经元素分析 ,IR ,1HNMR和MS确证 .测试了化合物 4c ,5 ,6对三种人癌细胞 (Bel 740 2 ,KB ,HCT 8)的体外生理活性 ,初步结果表明化合物 6比 4c和 5对三种所测细胞有更好的抑制效果 相似文献
4.
5.
6.
7.
8.
9.
N-茄呢基-N,N′-二(3,4-二甲氧基苄基)乙二胺的合成 总被引:3,自引:0,他引:3
癌症仍是需要攻克的医学难题之一. 虽然已有多种抗癌剂用于临床,但大多数抗癌剂是以细胞毒性来抑制癌细胞的繁殖,使用剂量受到限制,长期治疗还会产生毒副作用. 研究表明,N-茄呢基-N,N′-二(3,4-二甲氧基苄基)乙二胺(简称SDB-乙二胺)[1]具有优先作用于多种抗药性肿瘤的直接的细胞毒性,对几乎所有类型临床抗肿瘤药物具有增效作用,其中对抗生素类和生物碱类抗癌药物的增效尤为显著,如对其中的博莱霉素(争光霉素)、呱来霉素、磅霉素等,每毫升注射液含有3和10 μg的SDB-乙二胺,药效分别能提高47和130倍,对新制癌菌素(neocarzinostatin)也能提高2倍以上[2]. 与其他增效剂相比,SDB-乙二胺的增效作用具有定向细胞毒性,而本身完全没有细胞毒性,安全性好,可以连续使用,可减少抗癌剂的剂量,减轻毒副作用[3]. 因此,研究开发抗癌药物增效剂是癌症治疗的发展方向之一. 相似文献
10.
11.
12.
13.
14.
15.
The thiophene‐derived amido bis‐nitrogen mustard N2,N2,N5,N5‐tetrakis(2‐chloroethyl)‐3,4‐dimethylthiophene‐2,5‐dicarboxamide was designed and synthesized via five‐step reactions from commercially available 2‐chloroacetonitrile. This target compound was confirmed by 1H NMR, 13C NMR, MS, IR spectra and elemental analyses, and its structure was further characterized by X‐ray single‐crystal analysis. The biological activities for the title compound and some intermediates were evaluated in vitro for their antibacterial, antifungal and cytotoxic activities. The preliminary results showed that the title compound could inhibit efficiently the growth of the tested microorganisms including drug‐resistant bacteria MRSA to some extent. Moreover, the target compound was found to be effective against prostatic carcinoma cell line (PC‐3), breast carcinoma cell line (MCF‐7), colon carcinoma (LoVo) and lung cancer (A549). Especially, it gave selective antitumor efficacy against prostatic carcinoma cell line (PC‐3) at a low dose. 相似文献
16.
17.
N-(取代苯氨基硫代甲酰基)邻苯二甲酰胺酸的合成 总被引:2,自引:0,他引:2
本文用四种硫脲衍生物和一种脲衍生物同邻苯二甲酸杆进行单酰化反应, 筛选了最适宜反应条件, 避免了环状副产物, 合成了N-(取代萃氨基硫代甲酰基)邻苯二甲酸。 相似文献
18.
A new synthesized benzene nitrogen mustard was converted into glycosyl donor-trichloroacetimidate that was glycosylated with p-nitrophenol(glycosyl donors) to form β-lactosyl p-nitrobenzene under the protection of acetyl in a stereoselective manner, was prepared and evaluated for its cytotoxicity towards cultured K562 cell line. Methylthiazoy tetrazolium(MTT) assay, transmission electron microscopy(TEM), flow cytometry(FCM) and immunohistochemistry were utilized to explore the mechanisms of how the compound arrests the growth of HCT-T cells. This new synthesed benzene nitrogen mustard glucoside derivate(BNMGD) presented a lower toxicity to normal cells, but is significantly more toxic to K562 cells compared with nitrogen mustard, meanwhile it can induce the apoptosis of K562 cells. These results indicate that the new synthesized BNMGD can inhibit the growth of K562 cells and induce the apoptosis, and its cytotoxicity towards cultured K562 cell line is much more effective than that of nitrogen mustard. 相似文献
19.
LIU Tie-mei WANG Shu-sheng ZHU Guang-ze LI Ming-yang ZHANG Li-ping 《高等学校化学研究》2007,23(3):300-302
Antibody-directed enzyme prodrug therapy(ADEPT) is a new strategy for the treatment of cancer that has arisen in recent twenty years, the main merits of which are that it can improve the selectivity of anticancer drugs and reduce the side effects in remote tissue. In the present study, two prodrugs-glycosylated aromatic nitrogen mustard derivatives were synthesized. Glucose and lactose were converted into glycosyl donors-trichloroacetimidate; the obtained glycosyl donors were glycosylated with p-nitrophenol(glycosyl donors) to form β-glucosyl p-nitrobenzene and β-lactosyl p-nitrobenzene that were protected by acetyl in a stereoselective manner; the two products were reduced by zinc dust and then treated with ethylene oxide, afforded two glycosylated nitrogen mustard derivatives that were protected by acetyl; the last step was to deacetylate and then afforded the two target compounds that could be used as prodrugs of ADEPT for further Anti-tumor research. 相似文献